Abridge is a Healthtech company based in New York, NY. It has raised $758M in total funding. Latest round: Series D.
Abridge funding overview
Abridge is a Healthtech company based in New York, NY. Abridge has raised $758M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in July 2025. The round record for Abridge runs through 2025; nothing later has been disclosed. Investors on record include Andreessen Horowitz, Elad Gil, IVP, Union Square Ventures, Bessemer Venture Partners, Lightspeed Venture Partners and 4 others. 10 distinct backers are named across the disclosed rounds.
Abridge has raised $758M in total disclosed funding across the rounds on record.
Who has invested in Abridge?
Andreessen Horowitz, Elad Gil, IVP, Union Square Ventures, Bessemer Venture Partners, Lightspeed Venture Partners are named among the investors backing Abridge.
What was the latest Abridge funding round?
The most recent disclosed round is a Series D, announced in July 2025.
Where is Abridge based?
Abridge is based in New York, NY.
What sector does Abridge operate in?
Abridge is tracked under Healthtech from New York, NY, with $758M in disclosed funding.
When did Abridge last raise?
The last disclosed Abridge round closed in July 2025 at Series D.
We update the Abridge record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in New York and their backers are listed below.
